161 related articles for article (PubMed ID: 29256110)
1. Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.
Barbosa-Cobos RE; Lugo-Zamudio G; Flores-Estrada J; Becerril-Mendoza LT; Rodríguez-Henríquez P; Torres-González R; Moreno-Eutimio MA; Ramirez-Bello J; Moreno J
Clin Rheumatol; 2018 Apr; 37(4):901-908. PubMed ID: 29256110
[TBL] [Abstract][Full Text] [Related]
2. Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
Gonzalez-Ponce F; Gamez-Nava JI; Perez-Guerrero EE; Saldaña-Cruz AM; Vazquez-Villegas ML; Ponce-Guarneros JM; Huerta M; Trujillo X; Contreras-Haro B; Rocha-Muñoz AD; Carrillo-Escalante MO; Sanchez-Rodriguez EN; Gomez-Ramirez EE; Nava-Valdivia CA; Cardona-Muñoz EG; Gonzalez-Lopez L;
PLoS One; 2021; 16(9):e0255854. PubMed ID: 34506500
[TBL] [Abstract][Full Text] [Related]
3. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
Front Immunol; 2018; 9():2388. PubMed ID: 30420853
[TBL] [Abstract][Full Text] [Related]
5. [Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness].
Carotti M; Salaffi F; Mangiacotti M; Cerioni A; Giuseppetti GM; Grassi W
Reumatismo; 2007; 59(1):38-49. PubMed ID: 17435841
[TBL] [Abstract][Full Text] [Related]
6. Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.
Hurnakova J; Hulejova H; Zavada J; Komarc M; Hanova P; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Vencovsky J; Pavelka K; Senolt L
PLoS One; 2016; 11(11):e0165498. PubMed ID: 27832086
[TBL] [Abstract][Full Text] [Related]
7. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
[TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and its correlation with sonographic knee cartilage thickness and disease activity.
Sakthiswary R; Rajalingam S; Hussein H; Sridharan R; Asrul AW
Clin Rheumatol; 2017 Dec; 36(12):2683-2688. PubMed ID: 28889184
[TBL] [Abstract][Full Text] [Related]
9. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
Hurnakova J; Hulejova H; Zavada J; Hanova P; Komarc M; Mann H; Klein M; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Vencovsky J; Pavelka K; Senolt L
PLoS One; 2017; 12(8):e0183420. PubMed ID: 28832684
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular function in treatment-naive early rheumatoid arthritis.
Løgstrup BB; Deibjerg LK; Hedemann-Andersen A; Ellingsen T
Am J Cardiovasc Dis; 2014; 4(2):79-86. PubMed ID: 25006535
[TBL] [Abstract][Full Text] [Related]
13. Gray Scale and Power Doppler Ultrasonographic Findings in the Assessment of Disease Activity and Their Correlation with Disease Activity Parameters in Rheumatoid Arthritis.
Jindal S; Kaushik R; Raghuvanshi S; Kaushik RM; Kakkar R
Curr Rheumatol Rev; 2018; 14(2):153-162. PubMed ID: 28117013
[TBL] [Abstract][Full Text] [Related]
14. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
[TBL] [Abstract][Full Text] [Related]
15. Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report.
Shahmohamadnejad S; Vaisi-Raygani A; Shakiba Y; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Pourmotabbed T
Clin Biochem; 2015 Jan; 48(1-2):63-9. PubMed ID: 25179377
[TBL] [Abstract][Full Text] [Related]
16. Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis.
Yoo IS; Lee SY; Park CK; Lee JC; Kim Y; Yoo SJ; Shim SC; Choi YS; Lee Y; Kang SW
Int J Rheum Dis; 2018 Jan; 21(1):148-154. PubMed ID: 27315340
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers in patients with rheumatoid arthritis.
Shrivastava AK; Singh HV; Raizada A; Singh SK; Pandey A; Singh N; Yadav DS; Sharma H
Allergol Immunopathol (Madr); 2015; 43(1):81-7. PubMed ID: 24656623
[TBL] [Abstract][Full Text] [Related]
18. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
Kizaki K; Yamashita F; Hayashi T; Funakoshi N
Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
[TBL] [Abstract][Full Text] [Related]
19. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.
Schwedler C; Häupl T; Kalus U; Blanchard V; Burmester GR; Poddubnyy D; Hoppe B
Arthritis Res Ther; 2018 Mar; 20(1):44. PubMed ID: 29540200
[TBL] [Abstract][Full Text] [Related]
20. Power Doppler ultrasound monitoring of response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis.
Iagnocco A; Finucci A; Ceccarelli F; Perricone C; Iorgoveanu V; Valesini G
Rheumatology (Oxford); 2015 Oct; 54(10):1890-6. PubMed ID: 26070937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
